{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:40:26Z","timestamp":1790379626331,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jacc.2021.02.035","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T07:40:43Z","timestamp":1616053243000},"page":"1903-1921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Recent Randomized Trials of Antithrombotic Therapy for Patients\u00a0With\u00a0COVID-19"],"prefix":"10.1016","volume":"77","author":[{"given":"Azita H.","family":"Talasaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessam","family":"Kakavand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Aghakouchakzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Kordzadeh-Kermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin W.","family":"Van Tassell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azin","family":"Gheymati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Ariannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hossein","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Jamalkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sholzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros V.","family":"Konstantinides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan M.","family":"Krumholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnood","family":"Bikdeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2021.02.035_bib1","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19","volume":"76","author":"Piazza","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","article-title":"Anticoagulation, mortality, bleeding and pathology among patients hospitalized with COVID-19: a single health system study","volume":"76","author":"Nadkarni","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib3","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1055\/s-0040-1718532","article-title":"Venous thromboembolism in COVID-19","volume":"120","author":"Schulman","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2020.05.053","article-title":"High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients","volume":"76","author":"Voicu","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"6","author":"Nopp","year":"2020","journal-title":"Res Prac Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib6","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","article-title":"Incidence of venous thromboembolism and bleeding among hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"159","author":"Jim\u00e9nez","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2021.02.035_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective\u00a0cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib9","article-title":"Presenting characteristics, treatment patterns, and outcomes among patients with venous thromboembolism during hospitalization for COVID-19","author":"Fern\u00e1ndez-Capit\u00e1n","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib10","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.02.035_bib11","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.jacc.2020.08.059","article-title":"Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC Focus Seminar","volume":"76","author":"Giustino","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib12","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.jacc.2021.02.035_bib13","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2021.02.035_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/rth2.12397","article-title":"Potential role of platelets in COVID-19: implications for thrombosis","volume":"4","author":"Koupenova","year":"2020","journal-title":"Res Prac Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2020.10.005","article-title":"COVID-19\u2014a vascular disease","volume":"31","author":"Siddiqi","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib16","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/ajh.25979","article-title":"Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism","volume":"95","author":"Stefely","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jacc.2021.02.035_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","article-title":"COVID-19 update: Covid-19-associated coagulopathy","volume":"50","author":"Becker","year":"2020","journal-title":"J\u00a0Thromb Thrombolys"},{"key":"10.1016\/j.jacc.2021.02.035_bib18","article-title":"Neutrophil extracellular traps and thrombosis in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2021.02.035_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40256-020-00431-z","article-title":"Current overview on hypercoagulability in COVID-19","volume":"20","author":"Singhania","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2021.02.035_bib20","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1055\/s-0040-1714369","article-title":"Prevalence and impact of coagulation dysfunction in COVID-19 in China: a meta-analysis","volume":"120","author":"Jin","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/s-0040-1715841","article-title":"Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus","volume":"120","author":"Katneni","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib22","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1055\/s-0040-1715836","article-title":"Staging severity of COVID-19 according to hemostatic abnormalities (CAHA Score)","volume":"120","author":"Marchandot","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib24","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Frontiers Immunol"},{"key":"10.1016\/j.jacc.2021.02.035_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/CIRCULATIONAHA.120.047971","article-title":"The spectrum of cardiac manifestations in coronavirus disease 2019 (COVID-19)\u2014a systematic echocardiographic study","volume":"142","author":"Szekely","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.02.035_bib26","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2020.08.069","article-title":"Characterization of myocardial injury in patients with COVID-19","volume":"76","author":"Giustino","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST Guideline and Expert Panel Report","volume":"158","author":"Moores","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2021.02.035_bib28","author":"Andreini"},{"key":"10.1016\/j.jacc.2021.02.035_bib30","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib31","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-Art Review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib32","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients","volume":"18","author":"Llitjos","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID and coagulation: bleeding and thrombotic manifestations of SARS-CoV2 infection","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2021.02.035_bib34","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Middeldorp","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2021.02.035_bib36","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/bloodadvances.2020002496","article-title":"The management of venous thromboembolism in hospitalized patients with COVID-19","volume":"4","author":"Spyropoulos","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacc.2021.02.035_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID)","volume":"196","author":"Lemos","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2021.02.035_bib39","article-title":"Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial","author":"Gonzalez-Ochoa","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jacc.2021.02.035_bib40","series-title":"NIH ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients","year":"2020"},{"key":"10.1016\/j.jacc.2021.02.035_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04678-4","article-title":"Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Barco","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2021.02.035_bib42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.02.035_bib43","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib44","doi-asserted-by":"crossref","first-page":"100029","DOI":"10.1016\/j.tru.2020.100029","article-title":"Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels","volume":"2","author":"Weinberg","year":"2021","journal-title":"Thrombosis Update"},{"key":"10.1016\/j.jacc.2021.02.035_bib45","first-page":"1","article-title":"A\u00a0randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study","volume":"21","author":"Vanassche","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2021.02.035_bib46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1740774520943846","article-title":"Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): study design and methodology for an international, adaptive Bayesian randomized controlled trial","volume":"17","author":"Houston","year":"2020","journal-title":"Clin Trials"},{"key":"10.1016\/j.jacc.2021.02.035_bib47","doi-asserted-by":"crossref","first-page":"L211","DOI":"10.1152\/ajplung.00199.2020","article-title":"Heparin as a therapy for COVID-19: current evidence and future possibilities","volume":"319","author":"Hippensteel","year":"2020","journal-title":"Am J Physiol Lung Cell Mol"},{"key":"10.1016\/j.jacc.2021.02.035_bib48","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.7861\/clinmed.2020-0351","article-title":"Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19","volume":"20","author":"Conzelmann","year":"2020","journal-title":"Clin Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib49","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The randomized embedded multifactorial adaptive platform for community-acquired pneumonia (REMAP-CAP) study: rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jacc.2021.02.035_bib50","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMe2025674","article-title":"The RECOVERY platform","volume":"384","author":"Normand","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04840-y","article-title":"Atorvastatin and aspirin as adjuvant therapy in patients with SARS-CoV-2 infection: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Ghati","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2021.02.035_bib52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41423-020-0492-x","article-title":"Elevated serum levels of S100A8\/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients","volume":"17","author":"Chen","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jacc.2021.02.035_bib53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12325-020-01539-z","article-title":"Design and rationale of a randomized, double-blind, placebo-controlled, phase 2\/3 study evaluating dociparstat in acute lung injury associated with severe COVID-19","volume":"38","author":"Lasky","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacc.2021.02.035_bib54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5301\/IJAO.2011.8535","article-title":"Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study","volume":"34","author":"Maruyama","year":"2011","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jacc.2021.02.035_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.thromres.2020.09.027","article-title":"Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: rationale and design of the INSPIRATION\/INSPIRATION-S studies","volume":"196","author":"Bikdeli","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2021.02.035_bib56","unstructured":"Interim presentation. ATTACC, ACTIV-4a & REMAP-CAP multiplatform RCT: Results of interim analysis. Available at: https:\/\/www.attacc.org\/presentations. Accessed January 28, 2021."},{"key":"10.1016\/j.jacc.2021.02.035_bib57","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.thromres.2020.09.033","article-title":"Anticoagulation in COVID-19: randomized trials should set the balance between excitement and evidence","volume":"196","author":"Bikdeli","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2021.02.035_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04689-1","article-title":"Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Kharma","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2021.02.035_bib59","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/rth2.12395","article-title":"Study of alteplase for respiratory failure in SARS-Cov2\/COVID-19: study design of the Phase IIa STARS Trial","volume":"4","author":"Moore","year":"2020","journal-title":"Res Prac Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13049-020-00732-x","article-title":"Barriers and challenges in the process of including critically ill patients in clinical studies","volume":"28","author":"Dahlberg","year":"2020","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib61","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib62","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.02.035_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib64","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1182\/bloodadvances.2020003269","article-title":"A\u00a0toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies","volume":"4","author":"Siegal","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacc.2021.02.035_bib65","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/jth.15094","article-title":"Anticoagulant interventions in hospitalized patients with COVID-19: a scoping review of randomized controlled trials and call for international collaboration","volume":"18","author":"Tritschler","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib66","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2020.09.008","article-title":"Anticoagulation in COVID-19: it is time for high-quality evidence","volume":"76","author":"Lopes","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib67","first-page":"507151","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.jacc.2021.02.035_bib68","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1055\/s-0040-1713152","article-title":"Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research","volume":"120","author":"Bikdeli","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib69","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/M20-3255","article-title":"Thromboembolic findings in COVID-19 autopsies: pulmonary thrombosis or embolism?","volume":"173","author":"Deshpande","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib70","first-page":"e437","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.02.035_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.thromres.2020.11.030","article-title":"Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy","volume":"198","author":"Lawlor","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2021.02.035_bib72","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacc.2021.02.035_bib73","article-title":"The landscape of cardiovascular clinical trials in the United States initiated before and during COVID-19","volume":"9","author":"Selvaraj","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.02.035_bib74","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7326\/M20-2959","article-title":"COVID-19 clinical trials: a teachable moment for improving our research infrastructure and relevance","volume":"173","author":"Kimmel","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib75","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41581-020-00336-9","article-title":"Impact of the COVID-19 pandemic on clinical research","volume":"16","author":"Tuttle","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2021.02.035_bib76","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jacc.2020.05.041","article-title":"The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials","volume":"76","author":"Bagiella","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib77","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/rth2.12410","article-title":"Staying updated on COVID-19: social media to amplify science in thrombosis and hemostasis","volume":"4","author":"Makris","year":"2020","journal-title":"Res Prac Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.02.035_bib78","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41573-019-0034-3","article-title":"Adaptive platform trials: definition, design, conduct and reporting considerations","volume":"18","author":"Angus","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacc.2021.02.035_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3664-1","article-title":"Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols","volume":"20","author":"Park","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2021.02.035_bib80","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report","volume":"384","author":"Horby","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib81","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for COVID-19\u2014interim WHO SOLIDARITY trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ahj.2020.10.065","article-title":"Characteristics of clinical trials evaluating cardiovascular therapies for coronavirus disease 2019 registered on ClinicalTrials.gov: a cross sectional analysis","volume":"232","author":"Varshney","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.02.035_bib83","series-title":"FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency","year":"2020"},{"key":"10.1016\/j.jacc.2021.02.035_bib84","doi-asserted-by":"crossref","first-page":"e09","DOI":"10.15420\/cfr.2020.07","article-title":"Cardiovascular clinical trials in a pandemic: immediate implications of coronavirus disease 2019","volume":"6","author":"Spitzer","year":"2020","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jacc.2021.02.035_bib85","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.jacc.2020.09.594","article-title":"Regulation of cardiovascular therapies during the COVID-19 public health emergency","volume":"76","author":"Vaduganathan","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib86","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41569-020-00439-7","article-title":"The COVID-19 pandemic: a catalyst to improve clinical trials","volume":"17","author":"Gaba","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2021.02.035_bib88","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jamainternmed.2020.2904","article-title":"Characteristics and strength of evidence of COVID-19 studies registered on ClinicalTrials. gov \u201cletter","volume":"180","author":"Pundi","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib89","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJMsb1905390","article-title":"Creating a framework for conducting randomized clinical trials during disease outbreaks","volume":"382","author":"Dean","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.02.035_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000151","article-title":"On the value of preprints: an early career researcher perspective","volume":"17","author":"Sarabipour","year":"2019","journal-title":"PLoS Biol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721004587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721004587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:39:58Z","timestamp":1760017198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721004587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":87,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0735109721004587"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.02.035","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.04.21249227","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Randomized Trials of Antithrombotic Therapy for Patients\u00a0With\u00a0COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}